CEL-SCI Corporation

CEL-SCI Corporationverified

CVM

Price:

$1.08

Market Cap:

$7.42M

CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Its flagship immunotherapy candidate, Multikine, is currently undergoing Phase III clinical trials for the treatment of head and neck cancer. The company also develops and holds the patent for its preclinical Ligand Epitope Antigen Presentation System (LEAPS), an innovative T-cell modulation technology. This system is designed to stimulate the human immune system to fight a broad range of conditions, including bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and various cancers. CEL-SCI'...[Read more]

Industry

Biotechnology

IPO Date

1983-12-08

Stock Exchange

AMEX

Ticker

CVM

The PE Ratio as of June 2026 (TTM) for CEL-SCI Corporation (CVM) is -0.50

According to CEL-SCI Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.50. This represents a change of -69.91% compared to the average of -1.66 of the last 4 quarters.

CEL-SCI Corporation (CVM) Historical PE Ratio (quarterly & annually)

How has CVM PE Ratio performed in the past?

The mean historical PE Ratio of CEL-SCI Corporation over the last ten years is -6.10. The current -0.50 PE Ratio has changed 719.13% with respect to the historical average. Over the past ten years (40 quarters), CVM's PE Ratio was at its highest in in the December 2018 quarter at 19.34. The PE Ratio was at its lowest in in the September 2020 quarter at -25.58.

Quarterly (TTM)
Annual

Average

-6.10

Median

-3.50

Minimum

-17.45

Maximum

-0.04

CEL-SCI Corporation (CVM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of CEL-SCI Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 16.16%

Maximum Annual PE Ratio = -0.04

Minimum Annual Increase = -99.18%

Minimum Annual PE Ratio = -17.45

Quarterly (TTM)
Annual
YearPE RatioChange
2025-1.47-47.91%
2024-2.8236.75%
2023-2.06-50.70%
2022-4.18-69.45%
2021-13.68-21.60%
2020-17.4517.92%
2019-14.8016.16%
2018-0.09149.47%
2017-0.04-99.18%
2016-4.44121.16%

CEL-SCI Corporation (CVM) Average PE Ratio

How has CVM PE Ratio performed in the past?

The current PE Ratio of CEL-SCI Corporation (CVM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.12

5-year avg

-4.84

10-year avg

-6.10

CEL-SCI Corporation (CVM) PE Ratio vs. Peers

How is CVM’s PE Ratio compared to its peers?

CEL-SCI Corporation’s PE Ratio is greater than INmune Bio, Inc. (-0.79), greater than Barinthus Biotherapeutics plc (-0.52), greater than Mersana Therapeutics, Inc. (-2.07), greater than Aligos Therapeutics, Inc. (-0.61), greater than Kezar Life Sciences, Inc. (-1.18), greater than OnKure Therapeutics, Inc. (-0.98), less than Tempest Therapeutics, Inc. (-0.32), greater than X4 Pharmaceuticals, Inc. (-5.07), less than FibroGen, Inc. (0.18), greater than PDS Biotechnology Corporation (-1.75),

Build a custom stock screener for CEL-SCI Corporation (CVM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CEL-SCI Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CEL-SCI Corporation (CVM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CEL-SCI Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is CEL-SCI Corporation's PE Ratio?

How is the PE Ratio calculated for CEL-SCI Corporation (CVM)?

What is the highest PE Ratio for CEL-SCI Corporation (CVM)?

What is the 3-year average PE Ratio for CEL-SCI Corporation (CVM)?

What is the 5-year average PE Ratio for CEL-SCI Corporation (CVM)?

How does the current PE Ratio for CEL-SCI Corporation (CVM) compare to its historical average?